Filing Details
- Accession Number:
- 0001140361-13-044451
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-27 16:17:14
- Reporting Period:
- 2013-11-25
- Filing Date:
- 2013-11-27
- Accepted Time:
- 2013-11-27 16:17:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184149 | W Jonathan Ayers | One Idexx Drive Westbrook ME 04092 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-25 | 13,000 | $25.45 | 378,389 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-11-25 | 7,000 | $41.94 | 385,389 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-11-25 | 25,000 | $50.00 | 410,389 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-25 | 20,079 | $105.46 | 390,310 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-11-25 | 19,010 | $106.14 | 371,300 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-11-26 | 13,000 | $25.45 | 384,300 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-11-26 | 7,000 | $41.94 | 391,300 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-11-26 | 25,000 | $50.00 | 416,300 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-26 | 38,789 | $104.79 | 377,511 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-11-26 | 300 | $105.61 | 377,211 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-25 | 13,000 | $0.00 | 13,000 | $25.45 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-25 | 7,000 | $0.00 | 7,000 | $41.94 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-25 | 25,000 | $0.00 | 25,000 | $50.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-26 | 13,000 | $0.00 | 13,000 | $25.45 |
Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2013-11-26 | 7,000 | $0.00 | 7,000 | $41.94 |
Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2013-11-26 | 25,000 | $0.00 | 25,000 | $50.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
41,072 | 2014-02-04 | No | 4 | M | Direct | |
22,616 | 2014-02-13 | No | 4 | M | Direct | |
75,000 | 2014-02-13 | No | 4 | M | Direct | |
28,072 | 2014-02-04 | No | 4 | M | Direct | |
15,616 | 2014-02-13 | No | 4 | M | Direct | |
50,000 | 2014-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 49,000 | Indirect | By Ayers Family Trust |
Footnotes
- The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2013.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $104.91 to $105.90, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $105.91 to $106.43, inclusive.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $104.48 to $105.445, inclusive.
- Grant of options to buy shares of common stock becomes exercisable as to 22,000 shares on 02/05/2005, 02/05/2006, 02/05/2007 and 02/05/2008, and the remaining 18,072 shares on 02/05/2009.
- Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2008, 02/14/2009, 02/14/2010 and 02/14/2011, and the remaining 9,616 shares on 02/14/2012.
- Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date 02/14/2008 of the date of grant.